Form D · Biotechnology

Treovir, LLC

Bala Cynwyd, PA · CIK 0001825493

Offering snapshot reported Sep 24, 2021 · SEC filing

Reported sold
$287K
Offering amount: $1M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 16, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$144K$287KSep 29, 2020: $132,584.00Sep 29, 2020Sep 24, 2021: $287,000.00Sep 24, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$132,584 → $287,000
  • Reported investors4 → 6

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 24, 2021Amendment$287,000$154,416vs Sep 29, 20206SEC filing
Sep 29, 2020Initial$132,584No comparison4SEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-376577

Source: Form D, filed Sep 24, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Christini Director, Executive
G. Yancey Gillespie Director, Executive
James Markert Director
Richard Whitely Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
128 Penarth Road
Bala Cynwyd, PA, 19004